78%, according to interim phase 3 clinical data.India’s drug regulatory authority, the Central Drugs Standard Control Organization, authorized the vaccine for emergency use on January 3, 2021.
It can now be used to vaccinate people aged 18 and older. Beyond India, the vaccine is authorized for emergency use in 8 countries: Iran, Mexico, Nepal, the Philippines, Paraguay, Zimbabwe, Guyana, and Mauritius.Covaxin, also known as BBV152, is a type of whole-virus vaccine called an inactivated vaccine.
An inactivated vaccine incorporates a modified or dead version of the virus, in this case SARS-CoV-2, which cannot replicate and so cannot cause disease.The virus in an inactivated vaccine triggers an immune response and causes the body to produce.